These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24213308)

  • 1. Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A.
    Závada J; Sinikka Pesicková S; Rysavá R; Horák P; Hrncír Z; Lukác J; Rovensky J; Vítová J; Havrda M; Rychlík I; Böhmova J; Vlasáková V; Slatinská J; Zadrazil J; Olejárová M; Tegzova D; Tesar V
    Lupus; 2014; 23(1):69-74. PubMed ID: 24213308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study.
    Zavada J; Pesickova S; Rysava R; Olejarova M; Horák P; Hrncír Z; Rychlík I; Havrda M; Vítova J; Lukác J; Rovensky J; Tegzova D; Böhmova J; Zadrazil J; Hána J; Dostál C; Tesar V
    Lupus; 2010 Oct; 19(11):1281-9. PubMed ID: 20605876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.
    Arends S; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M; Berden JH;
    Ann Rheum Dis; 2012 Jun; 71(6):966-73. PubMed ID: 22128082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Cauli A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Ann Rheum Dis; 2010 Jan; 69(1):61-4. PubMed ID: 19155235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
    Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children.
    Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
    Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
    Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cyclophosphamide and other immunosuppressive drugs in the treatment of patients with lupus nephritis.
    Brugos B; Sebestyen L; Tarr T; Vincze Z
    Pharmazie; 2014 Jun; 69(6):442-4. PubMed ID: 24974578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of lupus nephritis with cyclosporine - an outcome analysis.
    Rihova Z; Vankova Z; Maixnerova D; Dostal C; Jancova E; Honsova E; Merta M; Rysava R; Tesar V
    Kidney Blood Press Res; 2007; 30(2):124-8. PubMed ID: 17396037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimum therapeutic approaches for lupus nephritis: what therapy and for whom?
    Boumpas DT; Sidiropoulos P; Bertsias G
    Nat Clin Pract Rheumatol; 2005 Nov; 1(1):22-30. PubMed ID: 16932624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Appraisal of renal failure reversing therapies in lupus nephritis].
    Yang X; Liang L; Zhan Z; Ye Y; Liu Y; Yu X; Chen W; Yin P
    Zhonghua Nei Ke Za Zhi; 2001 Feb; 40(2):113-6. PubMed ID: 11798566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with cyclosporine A improves SLE disease activity of Japanese patients with diffuse proliferative lupus nephritis.
    Kamijo Y; Hashimoto K; Takahashi K; Ehara T; Shigematsu H; Higuchi M
    Clin Nephrol; 2011 Aug; 76(2):136-43. PubMed ID: 21762646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients.
    Sazliyana S; Mohd Shahrir MS; Kong CT; Tan HJ; Hamidon BB; Azmi MT
    Lupus; 2011 Oct; 20(12):1260-6. PubMed ID: 21844115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
    Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
    Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.